Home > Companies > Healthcare Human Factors

Healthcare Human Factors

humanfactors.ca

Healthcare Human Factors is the largest Human Factors team dedicated to healthcare internationally. Acting as consultants, researchers, designers and evaluators, we are setting standards and developing best practices for human factors in healthcare, leading cultural change and making an impact locally and worldwide. Located within one of the largest academic health science centres in the world at University Health Network, we are embedded in the healthcare setting with access to clinical users and patients that we design, test and create for. We have state-of-the-art usability testing facilities geared for healthcare and attract private and public sector clients including hospitals, the Ministry of Health and Long-Term Care (MOHLTC), Ontario Medical Association (OMA), and Canada Health Infoway (CHI).

C-Suite On Deck

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Events

8th International Conference on Bio-Sensing Technology

Conference

Related News

ECOGEN LABORATORIES ANNOUNCES OPERATIONAL UPDATE AMID COVID-19 PANDEMIC

BioSpace | March 20, 2020

EcoGen Laboratories ("EcoGen"), the leading vertically-integrated manufacturer and supplier of high quality hemp genetics, hemp-derived specialty ingredients and finished products in North America, released the following statement today from the Company's Co-Founder and CEO Alexis Korybut regarding operational updates amid the COVID-19 pandemic....

Industrial Impact

LYGOS AND FLEXIBLE SOLUTIONS INTERNATIONAL ANNOUNCE REGISTRATION STATEMENT ON FORM S-4 RELATED TO PROPOSED MERGER

Lygos Inc | July 26, 2022

Lygos Inc., a vertically integrated biotechnology provider of sustainable specialty ingredients, and Flexible Solutions International Inc. a developer and manufacturer of biodegradable products, today announced that FSI has filed a registration statement on Form S-4 with the U.S. Securities and Exchange Commission on July 25, 2022 in connection with its proposed merger with Lygos. On April 18, 2022, Lygos and FSI announced a definitive merger agreement in an all-stock transaction ...

MedTech

ALLOY THERAPEUTICS ACQUIRES DEEPCDR BIOLOGICS TO BRING BIOINFORMATICS AND MACHINE LEARNING TO ITS ANTIBODY DISCOVERY OFFERING

Alloy Therapeutics | December 10, 2021

Alloy Therapeutics, a biotechnology ecosystem company, announced it has acquired deepCDR Biologics, a Basel, Switzerland-based developer of deep learning technology for antibody discovery and optimization. The team and technology stack will form new bioinformatics and machine learning capabilities for Alloy and will be fully integrated into Alloy Discovery Services complementary workflow and processes. Alloy will expand the Basel deepCDR site as a permanent Alloy research facility and will hire ...

Diagnostics

ZIVO BIOSCIENCE ANNOUNCE JOINING RUSSELL MICROCAP® INDEX MEMBERSHIP

Zivo | June 28, 2022

ZIVO Bioscience, Inc. is a U.S.-based R&D company dedicated to the study, development and commercialization of natural nutritional compounds and bioactive molecules derived from proprietary algal strains, announced joining the Russell Microcap® Index (^RUMIC) as a result of the Russell indexes annual reconstitution in 2022. Russell Microcap® Index membership that remains in place for a course of 12 months, means automatic inclusion in the appropriate value style and gr...